The Claim

Among patients with acute coronary syndrome, baseline low-density lipoprotein cholesterol (LDL-C) levels below 55 mg/dL are associated with a 51% higher adjusted risk of major adverse cardiac and cerebrovascular events within one year compared to higher LDL-C levels, despite more intensive lipid-lowering therapy, indicating that very low LDL-C in this population is a marker of heightened residual cardiovascular risk.

Source: Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Patients with acute coronary syndrome who have very low LDL cholesterol levels below 55 mg/dL experience 51% more major heart and brain events within a year than those with higher LDL levels, even when receiving stronger cholesterol-lowering treatment.

See the scientific wording

Among patients with acute coronary syndrome, those with baseline low-density lipoprotein cholesterol (LDL-C) levels below 55 mg/dL have a 51% higher adjusted risk of major adverse cardiac and cerebrovascular events (MACCE) within one year compared to those with higher LDL-C levels, despite being on more intensive lipid-lowering therapy, suggesting that very low LDL-C in this population is a marker of heightened residual cardiovascular risk rather than a direct cause of events.

Why this might work

When plaque buildup in arteries is very advanced, the body pulls cholesterol out of the blood to feed the growing plaques, making LDL-C levels drop. At the same time, these unstable plaques are more likely to rupture and block blood vessels, causing heart attacks or strokes.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study

    People who recently had a heart attack and already have very low 'bad' cholesterol are still more likely to have another heart or brain problem—not because low cholesterol is dangerous, but because their heart disease is more severe and harder to treat.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.